La OMS se opone al uso del remdesivir contra el COVID-19
La OMS recomendó el viernes que los pacientes con COVID-19 hospitalizados no reciban tratamiento con remdesivir porque este medicamento antiviral no evita las muertes ni las formas graves de la enfermedad. (Fuente: AFP)
- Redacción EC
- 21 de noviembre de 2020 03:36 p.m.
:quality(75)/cdn.jwplayer.com/v2/media/AR4gD0uW/poster.jpg)
:quality(75)/cdn.jwplayer.com/v2/media/GlCCccVk/poster.jpg)
:quality(75)/cdn.jwplayer.com/v2/media/SBJ02Sxm/poster.jpg)
:quality(75)/cdn.jwplayer.com/v2/media/Wg9cSLNh/poster.jpg)
:quality(75)/cdn.jwplayer.com/v2/media/oqBCZ29T/poster.jpg)
:quality(75)/cdn.jwplayer.com/v2/media/q51C3ulY/poster.jpg)
:quality(75)/cdn.jwplayer.com/v2/media/BkUbYF84/poster.jpg)
:quality(75)/cdn.jwplayer.com/v2/media/Fy4oc3cO/poster.jpg)
:quality(75)/cdn.jwplayer.com/v2/media/8Gof4fOt/poster.jpg)
:quality(75)/cdn.jwplayer.com/v2/media/UHD4gP7h/poster.jpg)
:quality(75)/cdn.jwplayer.com/v2/media/hE7kYrZL/poster.jpg)
:quality(75)/cdn.jwplayer.com/v2/media/WsQaWvhB/poster.jpg)
:quality(75)/cdn.jwplayer.com/v2/media/4sbG81fL/poster.jpg)
:quality(75)/cdn.jwplayer.com/v2/media/S5lsXSBc/poster.jpg)
:quality(75)/dvgnzpfv30f28.cloudfront.net/01-05-2021/t_2b207eb3bd934e0e812d81dd65b0615f_name_GEN_RICA.png)
:quality(75)/dvgnzpfv30f28.cloudfront.net/01-10-2021/t_89ab963049e24209bffc177712fda40b_name_file_640x360_600_v3_.jpg)